Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-01-05 1:52 pm Unchanged | 2020-12-31 | 13G | Bellerophon Therapeutics, Inc. BLPH | SABBY MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing History |
2021-01-05 1:45 pm Unchanged | 2020-12-31 | 13G | Titan Medical Inc. TMDIF | SABBY MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing History |
2021-01-05 12:18 pm Purchase | 2020-12-31 | 13G | Helius Medical Technologies, Inc. HSDT | SABBY MANAGEMENT LLC | 3,457 11.000% | 3,457![]() (New Position) | Filing History |
2021-01-05 11:45 am Purchase | 2020-12-31 | 13G | Aytu BioPharma, Inc. AYTU | SABBY MANAGEMENT LLC | 36,535 11.000% | 36,535![]() (New Position) | Filing History |
2021-01-05 11:03 am Purchase | 2020-12-31 | 13G | Asensus Surgical, Inc. ASXC | SABBY MANAGEMENT LLC | 4,985,523 11.000% | 607,106![]() (+13.87%) | Filing History |
2021-01-05 10:50 am Purchase | 2020-12-31 | 13G | Biocept, Inc. BIOC | SABBY MANAGEMENT LLC | 6,439 11.000% | 6,439![]() (New Position) | Filing History |
2021-01-05 10:06 am Sale | 2020-12-31 | 13G | Novan, Inc. NOVN | SABBY MANAGEMENT LLC | 0 0.000% | -333,333![]() (Position Closed) | Filing History |
2021-01-05 09:26 am Sale | 2020-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 0 0.000% | -288,462![]() (Position Closed) | Filing History |
2021-01-05 09:20 am Sale | 2020-12-31 | 13G | Lipocine Inc. LPCN | SABBY MANAGEMENT LLC | 0 0.000% | -197,726![]() (Position Closed) | Filing History |
2021-01-05 08:55 am Sale | 2020-12-31 | 13G | Outlook Therapeutics, Inc. OTLK | SABBY MANAGEMENT LLC | 81,253 11.000% | -66,385![]() (-44.96%) | Filing History |
2021-01-05 08:39 am Purchase | 2020-12-31 | 13G | LIANLUO SMART LTD LLIT | SABBY MANAGEMENT LLC | 179,619 11.000% | 179,619![]() (New Position) | Filing History |
2021-01-05 08:20 am Purchase | 2020-12-31 | 13G | ZOMEDICA CORP COM ZOMDF | SABBY MANAGEMENT LLC | 12,633,334 11.000% | 12,633,334![]() (New Position) | Filing History |
2021-01-05 07:58 am Sale | 2020-12-31 | 13G | Zosano Pharma Corporation ZSAN | SABBY MANAGEMENT LLC | 0 0.000% | -102,185![]() (Position Closed) | Filing History |
2021-01-05 07:45 am Purchase | 2020-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | SABBY MANAGEMENT LLC | 2,671 11.000% | 951![]() (+55.33%) | Filing History |
2021-01-04 6:42 pm Sale | 2020-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP | SABBY MANAGEMENT LLC | 0 11.000% | -2![]() (-91.91%) | Filing History |
2021-01-04 3:43 pm Purchase | 2020-12-31 | 13G | ReWalk Robotics Ltd. LFWD | SABBY MANAGEMENT LLC | 176,484 11.000% | 176,484![]() (New Position) | Filing History |
2021-01-04 2:02 pm Sale | 2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX | SABBY MANAGEMENT LLC | 34,633 11.000% | -7,034![]() (-16.88%) | Filing History |
2021-01-04 1:40 pm Purchase | 2020-12-31 | 13G | Intec Pharma Ltd NTEC | SABBY MANAGEMENT LLC | 49,254 11.000% | 49,254![]() (New Position) | Filing History |
2021-01-04 12:21 pm Purchase | 2020-12-31 | 13G | ToughBuilt Industries, Inc. TBLT | SABBY MANAGEMENT LLC | 103 11.000% | 103![]() (New Position) | Filing History |
2021-01-04 11:58 am Sale | 2020-12-31 | 13G | Co-Diagnostics, Inc. CODX | SABBY MANAGEMENT LLC | 0 0.000% | -1,379,311![]() (Position Closed) | Filing History |